Search for: "In Re: Vitamin C Antitrust Litig."
Results 1 - 20
of 20
Sorted by Relevance
|
Sort by Date
17 Feb 2012, 6:03 am
Class representatives and their counsel in the Vitamin C Antitrust Litigation have won another initial round in their suit alleging that Chinese vitamin C manufacturers conspired to fix prices and to limit the output of vitamin C exported to the United States. [read post]
17 Nov 2017, 10:29 am
On Tuesday Nov. 14, the Solicitor General filed a brief urging the Supreme Court to grant certiorari in In re Vitamin C Antitrust Litigation, an international antitrust case that raises important questions about international comity and the interpretation of foreign law. [read post]
30 Jan 2012, 3:00 am
The case is captioned In re Vitamin C Antitrust Litigation, 05-CV-0453 (E.D.N.Y), and is pending in the United States District Court for the Eastern District of New York. [read post]
13 Sep 2011, 12:20 pm
On September 6, 2011, the United States District Court for the Eastern District of New York denied summary judgment for vitamin C manufacturers in In re Vitamin C Antitrust Litig., MDL No. 1738 (Decision (Vit C)). [read post]
3 Feb 2012, 9:59 am
In re Vitamin C Antitrust Litigation, 2012 WL 251909 (E.D.N.Y. 2012). [read post]
20 Sep 2016, 8:08 am
Court of Appeals for the Second Circuit issued its decision in In re: Vitamin C Antitrust Litigation. [read post]
9 Feb 2012, 6:56 am
The manufacturers did not meet the burden of proof for the foreign sovereign compulsion defense, and their motion for summary judgment based upon that defense and the related doctrines of comity and act of state were denied.The case is In re Vitamin C Antitrust Litigation, 2012-1 Trade Cases ¶77,779; [read post]
7 Oct 2011, 3:00 am
In re Vitamin C Antitrust Litigation, 06-MD-1738 (BMC)(JO) (E.D.N.Y. [read post]
17 Oct 2013, 5:00 am
The trials on our agenda for this year are: In re Vitamin C Antitrust Litigation In March 2013, a federal court jury in Brooklyn, New York, returned a $54.1 million verdict (trebled to $162.3 million) in favor of a class of vitamin C buyers. [read post]
4 Nov 2016, 3:50 am
Court of Appeals for the Second Circuit’s deference to China’s interpretation of its own law in a recent judgment (In Re: Vitamin C Antitrust Litigation; Sept. 20, 2016) has multiple implications. [read post]
13 Jul 2018, 1:57 pm
” In re Vitamin C Antitrust Litigation, 837 F. 3d 175, 189 (2016). [read post]
7 Aug 2008, 12:49 pm
Securities case.In re Vitamins Antitrust Litigation, 183 Fed. [read post]
15 May 2017, 6:56 am
S & L Vitamins, Inc., 560 F. [read post]
22 Mar 2007, 5:34 am
Danek Medical, Inc., 182 F.3d 281, 287 (4th Cir. 1999); In re Vitamins Antitrust Litigation, 183 Fed. [read post]
21 Mar 2017, 2:04 pm
C. [read post]
26 Apr 2013, 9:03 am
Blood: No, they’re not planning to stop—they’re just ignoring the lawyer. [read post]
9 Aug 2008, 1:50 am
You can separately subscribe to the IP Thinktank Global week in Review at the Subscribe page: [duncanbucknell.com] Highlights this week included: The end of William Patry’s blog: (Patry Copyright Blog), (Excess Copyright), (Patently-O), (Chicago IP Litigation Blog), (Michael Geist), (The Fire of Genius), (Techdirt), (Patry Copyright Blog), Kitchin J clarifies scope of biotech patents, in particular gene sequence patents: Eli Lilly & Co v Human Genome Sciences:… [read post]
5 Sep 2008, 11:01 pm
: (Chinese Law Prof Blog), China – The intellectual property rights crisis: (Ezine @rticles) Europe European Court of Justice to consider trade mark questions in Case C-342/08 Makro Zelfbedieningsgroothandel e.a. [read post]
30 May 2008, 9:09 am
: (Spicy IP), India: DCGI preparing document to implement patent-registration linkage: (Spicy IP), New Zealand: Generic pharmaceutical companies taking advantage of NZ IP laws and medicines regulations: (International Law Office), Uganda: Cipla licenses ARV technology into Uganda: (Afro-IP), US: Money saved through generic prescriptions: (GenericsWeb), US: Government plans to keep close tab on drug patent settlements: (GenericsWeb), US: FTC reports 14 deals to delay generics in 2007: (GenericsWeb),… [read post]
25 Jul 2008, 7:04 am
You can separately subscribe to the IP Thinktank Global week in Review at the Subscribe page: [duncanbucknell.com] Highlights this week included: CAFC affirms validity and enforceability of Eisai’s compound patent on Aciphex; elucidates current standard for obviousness of chemical composition of matter patents: Eisai v Reddy’s Lab’s and Teva Pharma: (Orange Book Blog), (Patent Docs), (Patent Prospector), (IP Law360), (Hal Wegner), (Patent Baristas), Three-strikes scheme… [read post]
